Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

Conditions:   Nonsmall Cell Lung Cancer;   Performance Status Interventions:   Drug: Pembrolizumab;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Nab paclitaxel;   Other: Quality of Life Questionnaire, lung cancer-specific (QLQ-LC13);   Other: QLQ-C30 Global Health/Quality of Life Questionnaire;   Other: COPD Assessment Test and modified Medical Research Coun cil Dyspnea Patient Reported Outcomes;   Drug: Pemetrexed Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials